About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

British Experts Endorse Novartis' Eye Drug Lucentis

by VR Sreeraman on August 27, 2008 at 5:50 PM
Font : A-A+

 British Experts Endorse Novartis' Eye Drug Lucentis

Novartis said Wednesday its Lucentis eye treatment has been recommended by Britain's National Institute for Health and Clinical Excellence (NICE) as a cost-effective therapy to stave off blindness.

The Swiss pharmaceutical giant said in a statement that NICE had recommended Lucentis as "a cost-effective therapy for all eligible patients with wet age-related macular degeneration (AMD)," an eye disease that is the leading cause of blindness in people aged over 50.

Advertisement

NICE determines access to medicines for National Health Service (NHS) patients in England and Wales on the basis of cost-effectiveness.

In its guidance, NICE proposed that the first 14 injections of Lucentis in each affected eye will be funded by the NHS -- Britain's 60-year-old public-funded health service -- while the drug costs for any subsequent injections will be reimbursed by Novartis.
Advertisement

"When fully implemented, the NICE decision will ensure that patients have access to Lucentis for as long as they need to preserve or improve their vision," said Winifred Amoaku, vice-president of Britain's Royal College of Ophthalmologists.

Novartis also announced on Wednesday that its Glivec cancer treatment has been granted "priority review status" by the United States Food and Drug Administration (FDA) for post-surgery use to treat stomach tumours.

Priority review status accelerates the review timing from 10 to six months.

If approved, Glivec would become the first treatment option available to patients with gastrointestinal stromal tumours after surgery to reduce the risk of the disease recurring, Novartis said.

Source: AFP
SRM
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Eye Vision LASIK Surgery Facts Allergy Eye Drops Routine Eye Examination Quiz On Eye Donation Floppy Iris Syndrome Eyelid Bump 

Recommended Reading
Amblyopia
Amblyopia is the loss of one eye''s ability to see details. Amblyopia is otherwise known as lazy ......
Anatomy of the Eye - Animation
Interactive section of Medindia gives details regarding anatomy of the Eye...
Laser Eye Surgery - Animation
Interactive section of Medindia gives general information about Laser Eye Surgery...
Allergy Eye Drops
Eye allergies are treated with different types of eye drops such as lubricants, antihistamines, NSAI...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Eyelid Bump
Our eyelids protect our eyes and keep them moist. Swelling of the eyelid may be localized due to cha...
Floppy Iris Syndrome
Floppy iris syndrome is associated with a high risk of complications following cataract surgery....
Routine Eye Examination
A comprehensive eye exam can take an hour or more, depending on the doctor and the number and comple...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use